Physician profile
Randall S Meisner
NPI 1003869215
$10,422.96
in general payments reported to CMS, 2019-2025
12 companies · $2,997 in 2025
The $2,997 reported for 2025 was more than what 87% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $390 · 2021: $1,292 · 2022: $1,189 · 2023: $980 · 2024: $3,284 · 2025: $2,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,700 · Food and Beverage: $2,532 · Education: $29.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,700.00 |
| Food and Beverage | $2,531.99 |
| Education | $29.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $8,086.75 | 2019-2025 | Single Use Electrosurgical Snare Sd-400, Endoclot Phs, Endocuff Vision |
| Boston Scientific Corporation | $825.16 | 2019-2025 | Exalt Model D, Acquire, Radial Jaw 4 |
| Erbe USA INC | $734.53 | 2021-2023 | Erbe Vio3 |
| Janssen Biotech, INC. | $209.05 | 2025 | Tremfya |
| Abbvie INC. | $192.91 | 2020-2025 | |
| Apollo Endosurgery US INC | $112.47 | 2020 | |
| Genzyme Corporation | $92.16 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.00 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.70 | 2021-2025 | Eohilia |
| Medtronic, INC. | $37.56 | 2025 | Pillcam |
| Pfizer INC. | $22.53 | 2025 | |
| Intercept Pharmaceuticals, INC. | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Meisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.